-
FDA approves Valeant's Jublia
LAVAL, Quebec — Valeant Pharmaceuticals International announced that its subsidiary, Valeant Pharmaceuticals North America, received approval from the Food and Drug Administration for its new drug application for Jublia (efinaconazole 10% topical solution). The drug is the first topical triazole approved for the treatment of onychomycosis of the toenails, the company said.
-
QS/1 partnering with VUCA Health to offer on-demand prescription-specific videos
SPARTANBURG, S.C. — QS/1, a complete healthcare automation solutions provider, on Tuesday announced it is partnering with VUCA Health to offer on-demand prescription-specific videos, as well as other services to engage patients and strengthen customer relationships.
QS/1 pharmacies will be able to print QR codes on prescription labels that link to thousands of videos in the MedsOnCue library. The videos help patients review how to take their medications safely with easy to understand information on potential side effects and how to limit any avoidable reactions.